Nestlé’s 12Bln Deal to Help Regain Chinese Baby Food Market04-23 15:14 Caijing
Nestle SA has agreed to buy Pfizer’s infant-nutrition business with $11.9 billion, a move could help Nestle regain the Chinese baby food market, Bloomberg reported Monday.
Pfizer on Sunday chose Nestle over Danone SA , which also bid about $11 billion, Bloomberg quoted an anonymous source as saying.
The purchase will help Nestle, already the top seller of infant-nutrition products, regain traction in the Chinese baby- food market where Pfizer has a 7 percent share, according to the report.
Nestle has been losing market share in the country since 2005, when it withdrew two varieties of Neslac milk powder after authorities found they contained excessive iodine.
China's infant nutrition market is a highly competitive one led by Dumex and Mead-Johnson.
Statistics show Nestle had become the 3rd largest infant nutrition
manufacturer in the Chinese market with a 10.58% share, following 16.76%-share
Dumex and 12.06%-share Mead-Johnson by the end of July in 2010.
Editors’ Picks »
- 1China to Cut Reserve Ratio for Some Rural Banks
- 2China M2 up 12.1Pc, Outstanding Yuan Loans 13.9 Pc in March
- 3Delayed Response to Tainted Water Raises Concerns
- 4China's FDI Inflow down 1.47% in March
- 5China's MMG to Acquire Las Bambas
- 6China’s Rare Earth Exchange Begins Trading Following WTO Ruling
- 7Alibaba’s Q4 Net Income More than Doubles Ahead of IPO
- 8China Trade Fair Shadowed by Weak Exports
- 9Embassy Says 2 Chinese Nationals Aboard Capsized S.Korean Ship
- 10South Korean Ferry Sinks off South Coast